Peer Review History
| Original SubmissionNovember 13, 2024 |
|---|
|
PONE-D-24-52122ProteinWeaver: A Webtool to Visualize Ontology-Annotated Protein NetworksPLOS ONE Dear Dr. Ritz, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Aug 01 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Abozar Ghorbani, Ph.D Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please expand the acronym “DBI” (as indicated in your financial disclosure) so that it states the name of your funders in full. This information should be included in your cover letter; we will change the online submission form on your behalf. 3. Thank you for stating the following in the Acknowledgments Section of your manuscript: We thank Larry Zeng for his help with the web server and the tech stack architecture. We also thank Derek Applewhite, Kara Cerveny, and Shivani Ahuja for their collaborative discussions. This work was funded by NSF-DBI-1750981 (awarded to AR). We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: This work was supported by a National Science Foundation (https://www.nsf.gov/) grant NSF-DBI-1750981 awarded to AR. The funders not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 4. Thank you for uploading your study's underlying data set. Unfortunately, the repository you have noted in your Data Availability statement does not qualify as an acceptable data repository according to PLOS's standards. At this time, please upload the minimal data set necessary to replicate your study's findings to a stable, public repository (such as figshare or Dryad) and provide us with the relevant URLs, DOIs, or accession numbers that may be used to access these data. For a list of recommended repositories and additional information on PLOS standards for data deposition, please see https://journals.plos.org/plosone/s/recommended-repositories. 5. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 6. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: 1- Please clarify the reasons of choosing Yen’s and breadth-first search algorithms. 2- It is better to discuss the used algorithms and their potentials more in the results and discussion. 3- In this 5-model organisms based tool, E. coli is totally neglected. Although the authors brought the topic in Discussion section and trying to justify it, the reasons of this negligence were not enough. Reviewer #2: Hello dear authors Based on the manuscript, the following comments should be resolved before the final editor decision on the manuscript. 1. It is highly recommended to make a logical relationship between the following paragraph of “Introduction” section and the previous one, and highlight the importance of your study. “We present ProteinWeaver, a molecular interaction network visualization tool that generates subnetworks of physical and regulatory interactions based on a protein and a biological function of interest for non-human model organisms. In contrast to previous tools, ProteinWeaver links proteins to relevant biological processes, provides customizable network visualizations, and encourages interactive network exploration. To our knowledge,” 2. With reference to this sentence of “Introduction” section: “Currently, ProteinWeaver supports a prokaryote (the Gram-positive bacterium Bacillus subtilis subsp. subtilis str. 168), a single-celled eukaryote (the brewer’s yeast Saccharomyces cerevisiae S288C), two morphologically-distinct invertebrates (the fruit fly Drosophila melanogaster and the nematode Caenorhabditis elegans), and a vertebrate (the zebrafish Danio rerio)….” : It is very informative to select a representative from various organisms. However, it is highly encouraged to include a representative of viruses such as SARS-CoV-2 to make a comprehensive server that allow this valuable analysis workflow to users. 3. Some errors exist in the manuscript such as “single-celled” which should be replaced by “unicellular”. Moreover, all scientific names should be written in italics. 4. The Saccharomyces cerevisiae is considered as the unicellular eukaryote, but the yeasts are mainly considered as a prokaryote. 5. Table captions should be inserted above the Tables. Moreover, please cite this Table below the related text. It is not common to start the manuscript section with a table or figure. 6. Some grammar issues and vague sentences exist. So, it is highly recommended to revise the manuscript accordingly and resolve this issue. 7. Some repetitive structures exist throughout the manuscript such as the following one in “Materials and Methods” section: "Currently, ProteinWeaver supports a prokaryote (the Gram-positive bacterium Bacillus subtilis subsp. subtilis str. 168), etc...." The authors are highly encouraged to place this information here and remove it from introduction. 8. In “2.2.” section, Figure 3.A should be written as Figure 2. 9. It is not common to state both full structure and abbreviation of each term after the first definition. Please revise the manuscript. 10. It is not common to discuss the literatures in results section, unless results and discussion being mixed. 11. It is highly recommended to revise lengthy sentences like these: “We assessed the four methods by generating a dataset of 1,000 positives, which were selected by randomly choosing a protein-GO term edge and modifying G to remove that specific edge. We expect these nodes to have high confidence in their membership with the GO term. For every positive (protein-GO Term pair), we selected 100 negative proteins by identifying proteins that are (1) near the positive protein when considering PPI and regulatory edges only, (2) are not connected to the positive GO term, and (2) have approximately the same degree as the positive node.”. Such structures could confuse readers. Please revise the manuscript and resolve this issue accordingly. 12. It might that large explanations like this, with the nested examples confuse the readers and decrease the value of the server usage. It is highly recommended to revise the manuscript and resolve the similar structures like this: “We found that RandomWalk had a nearly perfect ROC AUC across all species (Figure 6. RandomWalk also had the highest precision at varying recall values and it drops off precision at higher recall values. The rest of the methods performed considerably worse than RandomWalk in the ROC AUC analysis. Between the methods, their ranks varied in different species analysis for both the inferred and non-inferred networks. For example, the degree method was ranked second in the ROC value for C. elegans, however was ranked 4th for the yeast dataset. The Precision/Recall values for the One-Hop GO Overlap and Degree methods noticed an increase when using the inferred networks. The significance of this increase varied among the methods and which species. For example, the degree method noticed the largest Precision/Recall increase in the C. elegans dataset. The Hypergeometric method, however, did not show any noticeable difference between the Precision/Recall values across all the species when using the inferred and non-inferred networks.” 13. The manuscript has many vague structures like “This could be because adding inferred protein-GO edges did not affect the overall hypergeometric equation used to calculate their scores. We also ran these methods on the graphs with only directly-annotated networks; while the relative ordering of the three comparator methods changed, the random walk approach remained superior”. Please revise whole document and correct it. 14. It is better to mention case studies in materials and methods section and only state the results here. 15. It is not necessary to redundant explanations such as the microtubule or BMPs importance. 16. All phrases about the gathered results should be write in past tense. 17. The authors have been provided a valuable web-server. However, it is recommended to improve the graphical representation. Sincerely ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
ProteinWeaver: A webtool to visualize ontology-annotated protein networks PONE-D-24-52122R1 Dear Dr. Ritz, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Abozar Ghorbani, Ph.D Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: (No Response) Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: N/A ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: (No Response) Reviewer #2: Hello dear authors Thanks for the valuable improvement of the manuscript. Please resolve the following comments before the final editor decision on the manuscript. 1. As it was pointed out in the previous review, it is not common to state both full structure and abbreviation of each term after the first definition. The first use of PPI, GRN, TF terms is in the "introduction section". There is an inconsistency throughout the manuscript, accordingly. The authors use the full structure and abbreviations following each other. Please revise the manuscript. 2. As it was pointed out in the previous version, all scientific names should be given in italics (e.g., line 224). Please revise whole manuscript and resolve this issue. 3. All phrases about the gathered results should be write in past tense. Sincerely ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Nastaran Asghari Moghaddam Reviewer #2: No ********** |
| Formally Accepted |
|
PONE-D-24-52122R1 PLOS ONE Dear Dr. Ritz, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Abozar Ghorbani Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .